NON-MELANOMA SKIN CANCER (NMSC)
Clinical trials for NON-MELANOMA SKIN CANCER (NMSC) explained in plain language.
Never miss a new study
Get alerted when new NON-MELANOMA SKIN CANCER (NMSC) trials appear
Sign up with your email to follow new studies for NON-MELANOMA SKIN CANCER (NMSC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
UK trial aims to repurpose existing drugs for rare and Hard-to-Treat cancers
Disease control Not yet recruitingThis trial is testing if two already-approved cancer drugs, dabrafenib and trametinib, can help patients with rare cancers or common cancers that have a rare, specific genetic change called a BRAF V600 mutation. The drugs are already used for some cancers like melanoma, but resea…
Matched conditions: NON-MELANOMA SKIN CANCER (NMSC)
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Could a simple scan make skin cancer surgery more precise?
Diagnosis Not yet recruitingThis study is testing if using a special high-frequency ultrasound scan before surgery helps doctors better map out skin cancers on the face, head, or neck. The goal is to see if this extra scan helps surgeons remove the entire tumor in one go, reducing the need for repeat surger…
Matched conditions: NON-MELANOMA SKIN CANCER (NMSC)
Sponsor: Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji • Aim: Diagnosis
Last updated Mar 24, 2026 12:02 UTC